REGULATED PRESS RELEASE published on 03/03/2025 at 17:35, 1 year 3 months ago Disclosure of transactions in own shares from February 24 to February 28, 2025
BRIEF published on 02/28/2025 at 08:35, 1 year 4 months ago Eurazeo to Acquire Majority Stake in Mapal from PSG Equity EURAZEO Investment Mapal Hospitality Software PSG Equity
REGULATED PRESS RELEASE published on 02/28/2025 at 08:30, 1 year 4 months ago EURAZEO TO INVEST IN MAPAL, A LEADING PAN-EUROPEAN HOSPITALITY SOFTWARE PROVIDER, ACQUIRING A MAJORITY STAKE FROM PSG EQUITY Eurazeo to invest in Mapal, a leading Pan-European hospitality software provider, acquiring a majority stake from PSG Equity. Transaction subject to regulatory approvals. Mapal focuses on AI-powered SaaS platforms for the hospitality sector EURAZEO Investment Mapal Hospitality Software AI-powered SaaS
BRIEF published on 02/27/2025 at 17:50, 1 year 4 months ago Eurazeo's EZORE Fund Acquires Italy's Largest Thermal Park Italy Real Estate Sustainability Investment Thermal Park
REGULATED PRESS RELEASE published on 02/27/2025 at 17:45, 1 year 4 months ago EURAZEO SIGNS EZORE FUND’S FIRST TRANSACTION WITH ACQUISITION OF AQUARDENS, ITALY’S LARGEST THERMAL PARK Eurazeo's first transaction through EZORE fund: acquisition of Aquardens, Italy's largest thermal park, to enhance customer offerings and drive sustainability, marking the debut of the innovative investment strategy Sustainability EURAZEO Aquardens Thermal Park EZORE Fund
REGULATED PRESS RELEASE published on 02/24/2025 at 17:35, 1 year 4 months ago Disclosure of transactions in own shares from February 17 to February 21, 2025
REGULATED PRESS RELEASE published on 02/17/2025 at 17:35, 1 year 4 months ago Disclosure of transactions in own shares from February 10 to February 14, 2025
BRIEF published on 02/12/2025 at 08:05, 1 year 4 months ago EURAZEO Leads €29 Million Series B for Germitec EURAZEO Healthcare Investment FDA Certification Germitec Disinfection Solutions
REGULATED PRESS RELEASE published on 02/12/2025 at 08:00, 1 year 4 months ago EURAZEO PARTICIPATES IN GERMITEC’S EUR 29 MILLION SERIES B FUNDRAISING Eurazeo participates in Germitec’s €29 million Series B fundraising to support the development of innovative High-Level Disinfection solutions for ultrasound probes. Nov Santé Actions Non Cotées is the lead investor EURAZEO Germitec Series B Fundraising High-Level Disinfection Ultrasound Probes
BRIEF published on 02/11/2025 at 17:40, 1 year 4 months ago EURAZEO Reports Share and Voting Rights Numbers as of January 31, 2025 Voting Rights EURAZEO AMF Regulations Capital Disclosure January 2025
Published on 06/30/2026 at 15:00, 1 hour 56 minutes ago Four Nines Gold Advances Toward Maiden Drill Program with Property-Wide Geophysical Survey at Hayden Hill
Published on 06/30/2026 at 15:00, 1 hour 56 minutes ago BlackBerry AtHoc Strengthens Enterprise Readiness as Cyber, Climate, and Geopolitical Uncertainty Rises
Published on 06/30/2026 at 15:00, 1 hour 56 minutes ago Presentation at ESPGHAN 2026 Describes Additional Groundbreaking Results of Evaluation of Jaguar Health's Crofelemer as Adjunctive Oral Therapy for the Treatment of Pediatric Intestinal Failure (IF)
Published on 06/30/2026 at 14:30, 2 hours 26 minutes ago NV Gold Announces Non-Brokered Private Placement
Published on 06/30/2026 at 14:00, 2 hours 56 minutes ago Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Published on 06/30/2026 at 16:34, 22 minutes ago hep global concludes fiscal year 2025 with a positive consolidated result
Published on 06/30/2026 at 16:05, 51 minutes ago Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
Published on 06/30/2026 at 07:30, 9 hours 26 minutes ago Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.
Published on 06/30/2026 at 07:00, 9 hours 56 minutes ago bioMérieux submits 510(k) to U.S. FDA for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens
Published on 06/29/2026 at 18:30, 22 hours 26 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms